ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$0.64 USD
+0.01 (1.74%)
Updated Dec 27, 2024 04:00 PM ET
After-Market: $0.62 -0.02 (-2.67%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/27/2025
Time: -- |
12/2024 | $-0.24 | 0.00% |
Earnings Summary
For their last quarter, ProPhase Labs (PRPH) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.31 per share. This reflects a negative earnings surprise of 12.90%. Look out for PRPH's next earnings release expected on March 27, 2025. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year increase of 52.94%.
Earnings History
Price & Consensus
Zacks News for PRPH
Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates
PRPH: What are Zacks experts saying now?
Zacks Private Portfolio Services